Those diabetes peeps need to understand that the word “complications” should not always be implied as a negative term; but it could as well be referred to as one of the smart features in a timepiece, measuring beyond just normal displays of an hour and time.

So finally a lot of excitement is in the air, after the launch of the latest smart watch app for glucose tracking. The wave of new releases has been excited to launch it, including some of the startups, one of which is named as PKVitality; claiming it to be the first ever application that is been embedded in a wearable device, measuring blood glucose level through the skin. Apparently, the said international company has developed a technology with the help of microneedles; as their special patented biosensors, placed underneath the watch face. These microneedles are programmed to painlessly penetrate through the uppermost interstitial layer of the skin; in order to analyze the glucose measures. Moreover, the device doesn’t continuously keep a check on blood glucose level, but the watch needs input to prompt it for glucose measurements. Although the startup expects its official launch in a couple of years, until then it has to pass through all the local and international regulations; it may come in an expected price range of 140-200$.

Meanwhile, considering the alarming prevalence of diabetes all over the world and the medico-economic burden, the disease is imposing on many developed countries; many biotech leaders are coming up with their latest diabetes-related innovations, artificial intelligence tools and smart alternative therapies, such as stem cells therapy.

Stem cells can be referred to as the body’s basic tools, designed for the integration of software i.e. cellular functions and hardware i.e. cells and organ structures. These stem cells can be newly named as the “Jarvis of Diabetes” by relating them with the famous Jarvis Al Interface, enabling proper integration of doctors and patients to assess treatment activities, calculate effective outcomes and further analyze for the causative factors, driving highs and lows. Stem cells can be referred to as new medical boons to regularize the body’s disoriented immune system, against further destruction of major insulin-producing cells; the cells tasked to produce insulin, which ultimately is required to convert blood sugar into energy.

The worldwide clinical trials and the scientific hardships are endorsing these nascent stem cells as the only path towards the successful discovery of diabetes treatment to generate enough number of functional pancreatic beta cells in order to reduce insulin dependency. Yet in the world of diabetes data as well as “complications”; it seems that we have a lot to look forward to!